Literature DB >> 21106764

ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation.

Yong-Jun Chen1, Meng Zhang, Dong-Min Yin, Lei Wen, Annie Ting, Pu Wang, Yi-Sheng Lu, Xin-Hong Zhu, Shu-Ji Li, Cui-Ying Wu, Xue-Ming Wang, Cary Lai, Wen-Cheng Xiong, Lin Mei, Tian-Ming Gao.   

Abstract

Neuregulin 1 (NRG1) is a trophic factor that acts by stimulating ErbB receptor tyrosine kinases and has been implicated in neural development and synaptic plasticity. In this study, we investigated mechanisms of its suppression of long-term potentiation (LTP) in the hippocampus. We found that NRG1 did not alter glutamatergic transmission at SC-CA1 synapses but increased the GABA(A) receptor-mediated synaptic currents in CA1 pyramidal cells via a presynaptic mechanism. Inhibition of GABA(A) receptors blocked the suppressing effect of NRG1 on LTP and prevented ecto-ErbB4 from enhancing LTP, implicating a role of GABAergic transmission. To test this hypothesis further, we generated parvalbumin (PV)-Cre;ErbB4(-/-) mice in which ErbB4, an NRG1 receptor in the brain, is ablated specifically in PV-positive interneurons. NRG1 was no longer able to increase inhibitory postsynaptic currents and to suppress LTP in PV-Cre;ErbB4(-/-) hippocampus. Accordingly, contextual fear conditioning, a hippocampus-dependent test, was impaired in PV-Cre;ErbB4(-/-) mice. In contrast, ablation of ErbB4 in pyramidal neurons had no effect on NRG1 regulation of hippocampal LTP or contextual fear conditioning. These results demonstrate a critical role of ErbB4 in PV-positive interneurons but not in pyramidal neurons in synaptic plasticity and support a working model that NRG1 suppresses LTP by enhancing GABA release. Considering that NRG1 and ErbB4 are susceptibility genes of schizophrenia, these observations contribute to a better understanding of how abnormal NRG1/ErbB4 signaling may be involved in the pathogenesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21106764      PMCID: PMC3003111          DOI: 10.1073/pnas.1010669107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Maturation of long-term potentiation induction rules in rodent hippocampus: role of GABAergic inhibition.

Authors:  Rhiannon M Meredith; Anna M Floyer-Lea; Ole Paulsen
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

2.  Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences.

Authors:  Hau-Jie Yau; Hsiao-Fang Wang; Cary Lai; Fu-Chin Liu
Journal:  Cereb Cortex       Date:  2003-03       Impact factor: 5.357

3.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Authors:  R G Phillips; J E LeDoux
Journal:  Behav Neurosci       Date:  1992-04       Impact factor: 1.912

4.  Bicuculline and picrotoxin block gamma-aminobutyric acid-gated Cl- conductance by different mechanisms.

Authors:  N Akaike; K Hattori; Y Oomura; D O Carpenter
Journal:  Experientia       Date:  1985-01-15

5.  Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition.

Authors:  H Wigström; B Gustafsson
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

6.  Presynaptic BDNF required for a presynaptic but not postsynaptic component of LTP at hippocampal CA1-CA3 synapses.

Authors:  Stanislav S Zakharenko; Susan L Patterson; Ioannis Dragatsis; Scott O Zeitlin; Steven A Siegelbaum; Eric R Kandel; Alexei Morozov
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

7.  Selective impairment of long-term but not short-term conditional fear by the N-methyl-D-aspartate antagonist APV.

Authors:  J J Kim; M S Fanselow; J P DeCola; J Landeira-Fernandez
Journal:  Behav Neurosci       Date:  1992-08       Impact factor: 1.912

8.  Neuregulin 1 and susceptibility to schizophrenia.

Authors:  Hreinn Stefansson; Engilbert Sigurdsson; Valgerdur Steinthorsdottir; Soley Bjornsdottir; Thordur Sigmundsson; Shyamali Ghosh; Jon Brynjolfsson; Steinunn Gunnarsdottir; Omar Ivarsson; Thomas T Chou; Omar Hjaltason; Birgitta Birgisdottir; Helgi Jonsson; Vala G Gudnadottir; Elsa Gudmundsdottir; Asgeir Bjornsson; Brynjolfur Ingvarsson; Andres Ingason; Sigmundur Sigfusson; Hronn Hardardottir; Richard P Harvey; Donna Lai; Mingdong Zhou; Daniela Brunner; Vincent Mutel; Acuna Gonzalo; Greg Lemke; Jesus Sainz; Gardar Johannesson; Thorkell Andresson; Daniel Gudbjartsson; Andrei Manolescu; Michael L Frigge; Mark E Gurney; Augustine Kong; Jeffrey R Gulcher; Hannes Petursson; Kari Stefansson
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

9.  Association study of neuregulin 1 gene with schizophrenia.

Authors:  J Z Yang; T M Si; Y Ruan; Y S Ling; Y H Han; X L Wang; M Zhou; H Y Zhang; Q M Kong; C Liu; D R Zhang; Y Q Yu; S Z Liu; G Z Ju; L Shu; D L Ma; D Zhang
Journal:  Mol Psychiatry       Date:  2003-07       Impact factor: 15.992

10.  The development of parvalbumin-immunoreactivity in the neocortex of the mouse.

Authors:  J A del Río; L de Lecea; I Ferrer; E Soriano
Journal:  Brain Res Dev Brain Res       Date:  1994-09-16
View more
  130 in total

Review 1.  The contribution of GABAergic dysfunction to neurodevelopmental disorders.

Authors:  Kartik Ramamoorthi; Yingxi Lin
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

2.  Heterosynaptic long-term potentiation at GABAergic synapses of spinal lamina I neurons.

Authors:  Henning Fenselau; Bernhard Heinke; Jürgen Sandkühler
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

3.  Finding a druggable target for schizophrenia.

Authors:  Beatriz Rico
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

4.  Dynamics of Hippocampal Protein Expression During Long-term Spatial Memory Formation.

Authors:  Natalia Borovok; Elimelech Nesher; Yishai Levin; Michal Reichenstein; Albert Pinhasov; Izhak Michaelevski
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

5.  Neuregulin directly decreases voltage-gated sodium current in hippocampal ErbB4-expressing interneurons.

Authors:  Megan J Janssen; Elias Leiva-Salcedo; Andres Buonanno
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

Review 6.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

7.  Disruption of hippocampal neuregulin 1-ErbB4 signaling contributes to the hippocampus-dependent cognitive impairment induced by isoflurane in aged mice.

Authors:  Xiao-Min Li; Fan Su; Mu-Huo Ji; Guang-Fen Zhang; Li-Li Qiu; Min Jia; Jun Gao; Zhongcong Xie; Jian-Jun Yang
Journal:  Anesthesiology       Date:  2014-07       Impact factor: 7.892

8.  Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AG.

Authors:  Huizhi Du; In-Kiu Kwon; Jimok Kim
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

9.  Structural Similarities between Neuregulin 1-3 Isoforms Determine Their Subcellular Distribution and Signaling Mode in Central Neurons.

Authors:  Detlef Vullhorst; Tanveer Ahmad; Irina Karavanova; Carolyn Keating; Andres Buonanno
Journal:  J Neurosci       Date:  2017-04-21       Impact factor: 6.167

10.  Rapid transient isoform-specific neuregulin1 transcription in motor neurons is regulated by neurotrophic factors and axon-target interactions.

Authors:  Jiajing Wang; Abdelkrim Hmadcha; Vaagn Zakarian; Fei Song; Jeffrey A Loeb
Journal:  Mol Cell Neurosci       Date:  2015-04-22       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.